NCATS highlights CTSI-supported study on new melanoma subtypes
Dr. Thomas Graeber, director of the Metabolomics Center and professor of molecular and medical pharmacology at UCLA, and his research team had their research featured on the NCATS News website for their recent findings that melanomas can be divided into four distinct subtypes according to their stages of differentiation. Cell subtypes that de-differentiated to a less-mature cell showed sensitivity to a type of self-inflicted cell death called ferroptosis.
The research, published in Cancer Cell, is the first to link ferroptosis to melanoma differentiation states. The work further reveals that certain subtypes of melanoma cells could be successfully treated using multiple therapies in combination with ferroptosis-inducing drugs.
Dr. Graeber received a voucher from CTSI to conduct gene-expression profiling.
Further reading:
Image source: UCLA
Image caption: Thomas Graeber, PhD, of UCLA.
Related Articles
Final NIH Training Grant Changes Released | Effective Jan. 25, 2025
Final instructions have been released for NRSA Training Grants submitted on or after January 25th, 2025.
The NIH continues to support training populations from underrepresented groups
As national and state policies evolve, the NIH remains committed to promoting pathways for potential trainees from all backgrounds.
Junior investigator Matthew Anderson receives Diversity Supplement from NIH
One way in which the National Institutes of Health (NIH) endeavors to be more inclusive is through its Diversity Supplement mechanism
"A Nurse's Laugh": Marsh Bull pens a poem about the hardworking nurses at UCLA CTRC
CTSI interviews CTRC patient, writer, and health advocate, Marsh Bull, on his treatment journey